Trovafloksacin
Trovafloksacin | |
Drugs.com | Monografija |
---|
Način primene | Intravenozno, oralno |
---|
|
Poluvreme eliminacije | 9,1 h - 12,2 |
---|
|
---|
|
CAS broj | 147059-72-1 Y |
---|
ATC kod | J01MA13 (WHO) |
---|
PubChem | CID 62959 |
---|
DrugBank | DB00685 Y |
---|
ChemSpider | 56670 Y |
---|
KEGG | C07664 Y |
---|
ChEMBL | CHEMBL428 Y |
---|
|
Formula | C20H15F3N4O3 |
---|
Molarna masa | 416,353 |
---|
[H][C@@]12CN(C[C@]1([H])C2N)C1=C(F)C=C2C(=O)C(=CN(C3=C(F)C=C(F)C=C3)C2=N1)C(O)=O
|
InChI=1S/C20H15F3N4O3/c21-8-1-2-15(13(22)3-8)27-7-12(20(29)30)17(28)9-4-14(23)19(25-18(9)27)26-5-10-11(6-26)16(10)24/h1-4,7,10-11,16H,5-6,24H2,(H,29,30)/t10-,11+,16? YKey:WVPSKSLAZQPAKQ-SOSAQKQKSA-N Y
|
|
---|
Trovafloksacin je organsko jedinjenje, koje sadrži 20 atoma ugljenika i ima molekulsku masu od 416,353 Da.[1][2]
Osobine
Reference
- ^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126. уреди
- ^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958. уреди
- ^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o.
- ^ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t. уреди
- ^ Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e. уреди
Literatura
Spoljašnje veze
|
---|
Antifolati (inhibira purinski metabolizam, i tim putem inhibira DNK i RNK sintezu) | |
---|
Inhibitori topoizomeraze/ hinoloni/ (inhibiraju DNK replikaciju) | |
---|
Anaerobni DNK inhibitori | |
---|
RNK sinteza | |
---|
| | |
bact(J1p,w,n,m)/virs(J5d,r,h)/fung/para(a,e,c,h,r),v,g
|
|
|
| Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |
|
|